LadRx Corp LADX
Trading Information
- Previous Close Price
- $0.11
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–2.20
- Bid/Ask
- $0.60 / $0.97
- Shares Outstanding
- 495,092.00
- Market Cap
- $5,446.01
- Volume/Avg
- 578 / 330
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
- Website
- https://www.ladrxcorp.com
Valuation
|
Metric
|
LADX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
LADX
Financial Strength
|
Metric
|
LADX
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
LADX
Profitability
|
Metric
|
LADX
|
|---|---|
Return on Assets (Normalized) | −405.53% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
LADX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|jC?>qqs | LOCK|#N>w! | $134B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|@#$?V<M | LOCK|Zvr$? | $82B | |||
| argenx SE ADR
ARGX
| LOCK|F!Z&@<d | LOCK|sYD | $54B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|?^N$HK$ | LOCK|jGy@% | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|J@!nm> | LOCK|fs | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|>@l^t^ | LOCK|B$r<Y | $30B | |||
| Incyte Corp
INCY
| LOCK|jPl<&@ | LOCK|Jz | $25B | |||
| Moderna Inc
MRNA
| LOCK|S?h>^Xv | LOCK|?v | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|hY$$Cz | LOCK|Fm | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|$d<??G | LOCK|p! | $16B |
United States